Akihiko Koyama

Dr Akihiko Koyama

Head, Integrated Biology Engine, Eisai

Akihiko Koyama, Ph.D., leads the AiM Integrated Biology Engine. His group focuses on generating preclinical data packages, which enable the IND filing of innovative therapeutic compounds for immune-dementia and immuno-oncology.

He has led multiple drug discovery collaboration programs with academic institutes in the United States, the United Kingdom and Japan targeting Alzheimer’s disease and Parkinson’s disease. He serves as a special researcher of the National Institute of Science and Technology policy in Japan.

Akihiko joined Eisai as a molecular biologist in neuroscience at Eisai Tsukuba Research Laboratories in 2003, where he contributed to drug discovery projects targeting Parkinson’s disease. In 2008, he served as a visiting scientist at the laboratory of Dr. Lennart Mucke at the Gladstone Institute of Neurological Disease, during which time he expanded his knowledge of the molecular mechanism of Alzheimer’s disease and Parkinson’s disease utilizing transgenic mice. After returning to Eisai, he served as a principal scientist in the Global Discovery group of Neuroscience and General Medicine Production Creation Unit, in which he worked on a cognitive enhancer program for Alzheimer’s disease. In 2011, he was assigned as the US head of neuroscience discovery and started his lab at the Eisai Andover site.

Akihiko received his Ph.D. from the University of Tokyo Graduate School of Pharmaceutical Sciences in 2003. He received his Master’s Degree in Pharmaceutical Sciences from the University of Tokyo in 2000, where he earned his Bachelor of Science degree in Pharmaceutical Sciences from in 1998.


Featured Speakers



evidera excelra genrubix signet at big data stemtrak

The event is a good opportunity for industry to come together and identify ways to understand and utilize big data in the advancement of patient care.

Dr Mark Roche, CEO, Avanti iHealth

Show the sponsors

Vote who is making waves in the industry!

Phacilitate will gather influencers and industry innovators together from across healthcare, academia, Big Pharma, government and technology innovators into an ebook. Find out more